Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: A systematic review and meta-analysis

Epilepsy and Behavior

Volumn 36, Issue , 2014, Pages 173-179

  Cheng, Ji Wei ^a   Zhang, Li Jun ^a   Hou, Yu Qing ^a   Zhao, Qing ^a   Zhang, Xiao Jing ^a   Chen, Xue Fen ^a   Bai, Yu ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chinese; Epilepsy; MDR1 C3435T; Meta analysis; Polymorphism

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; MULTIDRUG RESISTANCE PROTEIN 1; VALPROIC ACID; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ANTICONVULSANT THERAPY; ARTICLE; CHINA; CHINESE; EPILEPSY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; FACTUAL DATABASE; GENETIC PREDISPOSITION; GENETICS; STATISTICS AND NUMERICAL DATA;

ASIAN CONTINENTAL ANCESTRY GROUP; DATABASES, FACTUAL; EPILEPSY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; P-GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84904693626     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.05.007     Document Type: Article

References (49)

1. Sills G.J., Mohanraj R., Butler E., McCrindle S., Collier L., Wilson E.A., et al. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 2005, 46:643-647.
2. Szoeke C., Sills G.J., Kwan P., Petrovski S., Newton M., Hitiris N., et al. Multidrug-resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts. Epilepsia 2009, 50:1689-1696.
3. Chang L., Wang X.S. Investigation progress on the epidemiology of epilepsy in China. J Int Neurol Neurosurg 2012, 39(2):161-164.
4. Siddiqui A., Kerb R., Weale M.E., Brinkmann U., Smith A., Goldstein D.B., et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003, 348:1442-1448.
5. Nockel J., van den Engel N.K., Winter H., Hatz R.A., Zimmermann W., Kammerer R. Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene. BMC Cancer 2006, 6:57.
6. Schmidt D., Loscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 2005, 46:858-877.
7. Calatozzolo C., Pollo B., Botturi A., Dinapoli L., Carosi M., Salmaggi A., et al. Multidrug resistance proteins expression in glioma patients with epilepsy. J Neurooncol 2012, 110:129-135.
8. Komar A.A. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 2007, 8:1075-1080.
9. Seo T., Ishitsu T., Ueda N., Nakada N., Yurube K., Ueda K., et al. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 2006, 7:551-561.
10. Kwan P., Wong V., Ng P.W., Lui C.H., Sin N.C., Poon W.S., et al. Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese. Pharmacogenomics 2009, 10:723-732.
11. Sayyah M., Kamgarpour F., Maleki M., Karimipoor M., Gharagozli K., Shamshiri A.R. Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients. Epileptic Disord 2011, 13:155-165.
12. Kwan P., Baum L., Wong V., Ng P.W., Lui C.H., Sin N.C., et al. Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav 2007, 11:112-117.
13. Tan N.C., Heron S.E., Scheffer I.E., Pelekanos J.T., McMahon J.M., Vears D.F., et al. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 2004, 63:1090-1092.
14. Shahwan A., Murphy K., Doherty C., Cavalleri G.L., Muckian C., Dicker P., et al. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res 2007, 73:192-198.
15. Sterjev Z., Trencevska G.K., Cvetkovska E., Petrov I., Kuzmanovski I., Ribarska J.T., et al. The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy. Neuropsychiatr Dis Treat 2012, 8:191-196.
16. Ameyaw M.M., Regateiro F., Li T., Liu X., Tariq M., Mobarek A., et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001, 11:217-221.
17. Kimchi-Sarfaty C., Marple A.H., Shinar S., Kimchi A.M., Scavo D., Roma M.I., et al. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics 2007, 8:29-39.
18. Hung C.C., Tai J.J., Lin C.J., Lee M.J., Liou H.H. Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics 2005, 6:411-417.
19. Hung C.C., Jen Tai J., Kao P.J., Lin M.S., Liou H.H. Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses. Pharmacogenomics 2007, 8:1151-1158.
20. Haerian B.S., Lim K.S., Tan H.J., Mohamed E.H., Tan C.T., Raymond A.A., et al. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. Epileptic Disord 2011, 13:65-75.
21. Haerian B.S., Lim K.S., Mohamed E.H., Tan H.J., Tan C.T., Raymond A.A., et al. Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. Seizure 2011, 20:387-394.
22. Dong L., Luo R., Tong Y., Cai X., Mao M., Yu D. Lack of association between ABCB1 gene polymorphisms and pharmacoresistant epilepsy: an analysis in a western Chinese pediatric population. Brain Res 2011, 1391:114-124.
23. Lu J.C., Ren H.M., Zhu G.X. Association of the C3435T polymorphism in the multidrug resistance gene 1 and response to antiepileptic drug treatment in epilepsy patients. Chin J Neurol 2007, 40(9):584-587.
24. Zheng X.Z., Wu S.J., Xia M. Association of a polymorphism in MDR1 C3435T with response to antiepileptic drugs treatment inintractable epilepsy. J Apoplexy Nerv Dis 2009, 26(1):44-46.
25. Ding Y.Y., Yang F., Liu J. Effects of the multidrug resistance 1 gene haplotype on resistance of valproic acid in Chinese Han Epilepsy patients. Chin J Clin Pharmacol Ther 2010, 15(11):1267-1271.
26. Dong T., Xu X.R., Qi M.S. Association analysis of ABCB1 C3435T polymorphism and drug -resistant epilepsy in Hui and Han-nation epilepsy patients. J Apoplexy Nerv Dis 2011, 28(3):237-241.
27. Gao X., Zhou S.Z., Guo Q. Polymorphism of MDR1 in childhood refractory epilepsy. J Clin Pediatr 2009, 27(11):1014-1018.
28. Wang S.Y., Gao F., Xia Z.Z. Association of a polymorphism in MDR1 C3435T with intractable epilepsy of children. Zhejiang Med J 2008, 30(12):1307-1310.
29. Chen L., Liu C.Q., Hu Y., Xiao Z.T., Chen Y., Liao J.X. Association of a polymorphism in MDR1 C3435T with response to antiepileptic drug treatment in ethic Han Chinese children with epilepsy. Chin J Contemp Pediatr 2007, 9(1):11-14.
30. Guo G.M., Guo Y.J., Lin W.H. Association study of C3435T genetic polymorphism of MDR1 gene with efficacy of carbamazepine. J Apoplexy Nerv Dis 2010, 27(2):128-130.
31. Jin R.F., Yang C.Y., Xu X.S. Frequency of the C3435T polymorphism in MDR1 genes and association of the polymorphisms with multidrug-resistant epilepsy. Chin J Clin 2010, 4(11):2153-2157.
32. Wang X.Y., Lin R.F., Shi D.H. Association of C3435T polymorphism in multidrug resistance gene 1 with refractory epilepsy. Prog Mod Biomed 2011, 11(14):2717-2719.
33. Di Q., Wang L.L., Xu L.G. Association between the C3435T polymorphism of human multidrug resistance 1 gene and refractory epilepsy. Chin J Neuromed 2011, 10(2):127-131.
34. Yang M.L., Li T., Huang Y.H. The relationship between genetic polymorphism and expressed matter of MDR1 gene with efficacy of carbamazepine. Chin J Diffic Complicat Cases 2012, 11(8):594-596.
35. Dong T., Xu X.R., Zhang Q. Association between 1 C3435T and drug resistant epilepsy in Ningxia Hui epilepsy patients. J Ningxia Med Univ 2011, 33(2):108-111.
36. Basic S., Hajnsek S., Bozina N., Filipcic I., Sporis D., Mislov D., et al. The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood-brain barrier in patients with generalized epilepsy. Seizure 2008, 17:524-530.
37. Lovric M., Bozina N., Hajnsek S., Kuzman M.R., Sporis D., Lalic Z., et al. Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy. Ther Drug Monit 2012, 34:518-525.
38. Loscher W., Klotz U., Zimprich F., Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 2009, 50:1-23.
39. Soranzo N., Cavalleri G.L., Weale M.E., Wood N.W., Depondt C., Marguerie R., et al. Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome Res 2004, 14:1333-1344.
40. Lakhan R., Misra U.K., Kalita J., Pradhan S., Gogtay N.J., Singh M.K., et al. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Epilepsy Behav 2009, 14:78-82.
41. Bournissen F.G., Moretti M.E., Juurlink D.N., Koren G., Walker M., Finkelstein Y. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. Epilepsia 2009, 50:898-903.
42. Haerian B.S., Roslan H., Raymond A.A., Tan C.T., Lim K.S., Zulkifli S.Z., et al. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis. Seizure 2010, 19:339-346.
43. Wang P., Xia H.H., Zhang J.Y., Dai L.P., Xu X.Q., Wang K.J. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer 2007, 120(3):552-562.
44. Li P., Qin C. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and susceptibility to ischemic stroke: a meta-analysis. Gene 2014, 535(2):359-364.
45. Marie S.K., Shinjo S.K., Oba-Shinjo S.M., da Silva R., Barbosa K.C., Yamamoto F., et al. Methylenetetrahydrofolate reductase gene polymorphism is not related to the risk of ischemic cerebrovascular disease in a Brazilian population. Clinics (Sao Paulo) 2007, 62(3):295-300.
46. Baltes S., Fedrowitz M., Tortos C.L., Potschka H., Löscher W. Valproic acid is not a substrate for p-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays. J Pharmacol Exp Ther 2007, 320:331-343.
47. Ufer M., Mosyagin I., Muhle H., Jacobsen T., Haenisch S., Häsler R. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2-24C>T polymorphism in young and adult patients with epilepsy. Pharmacogenet Genomics 2009, 19:353-362.
48. Sills G.J., Szoeke C., Kwan P., Petrovski S., Newton M., Hitiris N. Multidrug-resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts. Epilepsia 2009, 50:1689-1696.
49. Seo T., Ishitsu T., Ueda N., Nakada N., Yurube K., Ueda K. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 2006, 7:551-561.